To import and distribute a medicine in Malaysia, three things generally need to line up: the product must be registered with the National Pharmaceutical Regulatory Agency (NPRA) (it carries a Marketing Authorisation (MA) number), the responsible party must hold the appropriate licences (an import licence and a wholesale / distribution licence), and the operation must comply with Good Distribution Practice (GDP). A foreign manufacturer cannot do this directly from abroad - a locally incorporated entity holds the registration (the Marketing Authorisation Holder, MAH) and the licences. Registration comes first; the licences and logistics follow.
Getting a product approved is only half of market entry. The other half is the legal machinery that lets it physically enter the country and reach pharmacies, hospitals and clinics - import, wholesale and distribution, each governed by its own licence and by Good Distribution Practice (GDP). This guide explains what that machinery is, the order it has to happen in, and who can operate it on a foreign manufacturer's behalf.
The legal framework
Pharmaceuticals in Malaysia are governed mainly by the Poisons Act 1952, the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984 (CDCR 1984), administered by the Ministry of Health (MOH) through the Pharmaceutical Services Programme and the National Pharmaceutical Regulatory Agency (NPRA). The core principle: a product must be a registered product, and the parties importing, wholesaling and distributing it must hold the appropriate licences.
Registration comes first
Before import or distribution, the medicine must be registered with NPRA and carry an MA number; only a locally incorporated Marketing Authorisation Holder (MAH) can hold that registration (see our guide to drug registration in Malaysia and the article on keeping control of your registration). Importing or supplying an unregistered product is generally not permitted, outside narrow, specifically authorised exceptions. In practice: no registration, no legal import.
The licences involved
Distinct licences typically apply (confirm exact names and types against current MOH guidance - NPRA publishes a "Guideline on Application of Manufacturer's, Import and Wholesale Licence"):
- Import licence - to bring the registered product into Malaysia.
- Wholesale / distribution licence - to sell and supply to pharmacies, clinics, hospitals and other authorised buyers.
- Manufacturer's licence (where relevant) - for local manufacture or repackaging.
The holder of these licences is a Malaysian entity. A foreign manufacturer does not hold them directly; it works through a locally incorporated partner.
Good Distribution Practice (GDP)
Distribution must comply with Good Distribution Practice (GDP) - the standards that keep a medicine's quality intact from the point it enters the country to the point it reaches the patient. GDP covers storage conditions (including cold chain where required), traceability, handling of returns and recalls, and qualified personnel. A distributor's GDP compliance is not a formality: it is what protects the product - and your brand - across the supply chain.
How the pieces fit: order of operations
- Appoint a locally incorporated Marketing Authorisation Holder (MAH) to hold the registration.
- Register the product with NPRA (see the registration guide) to obtain the MA number.
- Ensure the import licence and wholesale / distribution licence are in place with the responsible local entity.
- Distribute through a GDP-compliant operation, matched to your product (cold chain, hospital vs retail, volume).
- Maintain everything: variations, renewals, pharmacovigilance and GDP over the product's life.
In Malaysia, import and distribution sit on top of registration: register first (via a local Marketing Authorisation Holder), hold the right import and wholesale licences, and run a Good Distribution Practice (GDP)-compliant operation - all through a locally incorporated partner.
Frequently asked questions
Can a foreign company import its own drugs into Malaysia?
Not directly. The product must be registered with the National Pharmaceutical Regulatory Agency (NPRA) and the importer/distributor must hold the appropriate Malaysian licences. A foreign manufacturer works through a locally incorporated entity that holds the registration (Marketing Authorisation Holder, MAH) and the licences.
What licences are needed to distribute pharmaceuticals in Malaysia?
Typically an import licence and a wholesale / distribution licence (plus a manufacturer's licence for local manufacture), held by a Malaysian entity, with the operation compliant with Good Distribution Practice (GDP). Confirm the exact licence categories against current Ministry of Health (MOH) guidance.
Do I need registration before I can import?
Yes - as a rule, a product must be registered with NPRA (and carry an MA number) before it can be legally imported and distributed, apart from narrow authorised exceptions.
What is GDP and why does it matter?
Good Distribution Practice (GDP) is the set of standards ensuring a medicine's quality is maintained through storage and distribution - including cold chain, traceability, and recall handling. Distributors must be GDP-compliant.
You might also find useful
- Pharmaceutical Distributors in Malaysia (2026): Top Companies and How to Choose
- Drug Registration in Malaysia: Process, Timeline and Requirements (2026)
- Sources:
- Ministry of Health Malaysia (MOH), Pharmaceutical Services Programme: pharmacy.gov.my
- NPRA - registration, Good Distribution Practice, and the "Guideline on Application of Manufacturer's, Import and Wholesale Licence": npra.gov.my
- Legislation: Poisons Act 1952; Sale of Drugs Act 1952; Control of Drugs and Cosmetics Regulations 1984: lom.agc.gov.my
- Editorial note: This article is general business and regulatory information for manufacturers evaluating Malaysia. It is not legal or regulatory advice. Licence categories, requirements and GDP standards should be confirmed against current MOH/NPRA guidance before acting.